(Q48090023)

8 February 2018

title

Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia (English)

1 reference

8 February 2018

0 references

0 references

Dayan B Goodenowe

1

1 reference

8 February 2018

Lisa L Cook

2

1 reference

8 February 2018

Jun Liu

3

1 reference

8 February 2018

Yingshen Lu

4

1 reference

8 February 2018

Dushmanthi A Jayasinghe

5

1 reference

8 February 2018

Pearson W K Ahiahonu

6

1 reference

8 February 2018

Doug Heath

7

1 reference

8 February 2018

Yasuyo Yamazaki

8

1 reference

8 February 2018

John Flax

9

1 reference

8 February 2018

Kevin F Krenitsky

10

1 reference

8 February 2018

D L Sparks

11

1 reference

8 February 2018

Alan Lerner

12

1 reference

8 February 2018

Robert P Friedland

13

1 reference

8 February 2018

Takashi Kudo

14

1 reference

8 February 2018

Kouzin Kamino

15

1 reference

8 February 2018

Takashi Morihara

16

1 reference

8 February 2018

Masatoshi Takeda

17

1 reference

8 February 2018

Paul L Wood

18

1 reference

8 February 2018

publication date

30 July 2007

1 reference

8 February 2018

Journal of Lipid Research

published in

1 reference

8 February 2018

volume

48

1 reference

8 February 2018

issue

11

1 reference

8 February 2018

page(s)

2485-2498

1 reference

8 February 2018

Dementia--epidemiological considerations, nomenclature, and a tacit consensus definition

cites work

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Lipid alterations in the earliest clinically recognizable stage of Alzheimer's disease: implication of the role of lipids in the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

A reevaluation of the duration of survival after the onset of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Peroxisomal disorders: clinical, biochemical, and molecular aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Plasmalogens: biosynthesis and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Plasmenylcholine and phosphatidylcholine membrane bilayers possess distinct conformational motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Is the high propensity of ethanolamine plasmalogens to form non-lamellar lipid structures manifested in the properties of biomembranes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Rapid plasmenylethanolamine-selective fusion of membrane bilayers catalyzed by an isoform of glyceraldehyde-3-phosphate dehydrogenase: discrimination between glycolytic and fusogenic roles of individual isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Peroxisomal disease cell lines with cellular plasmalogen deficiency have impaired muscarinic cholinergic signal transduction activity and amyloid precursor protein secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Deficiency in ethanolamine plasmalogen leads to altered cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Plasmalogen phospholipids are involved in HDL-mediated cholesterol efflux: insights from investigations with plasmalogen-deficient cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Isolation of animal cell mutants deficient in plasmalogen biosynthesis and peroxisome assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Severe deficiency of docosahexaenoic acid in peroxisomal disorders: a defect of delta 4 desaturation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Plasmalogen metabolism-related enzymes in rat brain during aging: influence of n-3 fatty acid intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Effect of age on the expression of antioxidant enzymes in male Fischer F344 rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Cerebral beta amyloid deposition in patients with malignant neoplasms: its prevalence with aging and effects of radiation therapy on vascular amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Prevalence of Alzheimer plaques in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Delta-6 desaturation of alpha-linolenic acid in brain and liver during development and aging in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Alzheimer's disease: the cholesterol connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Age-dependence of molecular and functional changes in biological membrane properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Membrane dynamics, cholesterol homeostasis, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Oxidative injury of synapse and alteration of antioxidative defense systems in rats, and its prevention by vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Neuropathology of older persons without cognitive impairment from two community-based studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Intraventricular Bethanecol Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Cholinesterase inhibitors slow decline in executive functions, rather than memory, in Alzheimer's disease: a 1-year observational study in the Sunnybrook dementia cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Memory and cognitive function in man: Does the cholinergic system have a specific role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Choline increases acetylcholine release and protects against the stimulation-induced decrease in phosphatide levels within membranes of rat corpus striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Choline metabolism as a basis for the selective vulnerability of cholinergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

"Autocannibalism" of choline-containing membrane phospholipids in the pathogenesis of Alzheimer's disease-A hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Evidence for a membrane defect in Alzheimer disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

The choline transporter resurfaces: new roles for synaptic vesicles?

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Apoptosis of astrocytes with enhanced lysosomal activity and oligodendrocytes in white matter lesions in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

White matter lesions are associated with progression of medial temporal lobe atrophy in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Progression of cerebral white matter lesions in Alzheimer's disease: a new window for therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Mild cognitive impairment represents early-stage Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Oxidative mechanisms in beta-amyloid cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Increasing plasmalogen levels protects human endothelial cells during hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Peroxisomal proliferation protects from beta-amyloid neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

Membrane docosahexaenoate is supplied to the developing brain and retina by the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.P700023-JLR200

10.1194/JLR.P700023-JLR200

21 January 2018

Identifiers

DOI

1 reference

8 February 2018

1 reference

8 February 2018